Beractant
- Generic Name
- Beractant
- Brand Names
- Survanta
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 108778-82-1
- Unique Ingredient Identifier
- S866O45PIG
- Background
Beractant is a pulmonary surfactant used for the treatment of Respiratory Distress Syndrome (RDS) in premature infants. Considered a natural source of surfactant as it is made from bovine lung extract, beractant contains a mixture of phospholipids, neutral lipids, fatty acids, and surfactant-associated proteins such as SP-B and SP-C. The final composition pr...
- Indication
Beractant is indicated for prevention and treatment of Respiratory Distress Syndrome (RDS) in premature infants.
- Associated Conditions
- Respiratory Distress Syndrome
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath